Skip to main content
TipRanks
Go Ultimate75% OFF

PolyPeptide Group AG (PLYGF) Financial Statements

0 Followers

PolyPeptide Group AG Financial Overview

PolyPeptide Group AG's market cap is currently €1.59B. The company's EPS TTM is €0.43; its P/E ratio is 101.45; PolyPeptide Group AG is estimated to report earnings on March 9, 2027, and the estimated EPS forecast is €0.44. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 391.87M€ 338.69M€ 320.37M€ 280.98M€ 282.13M
Gross Profit€ 64.32M€ 39.27M€ 4.77M€ 51.99M€ 99.70M
Operating Income€ 7.41M€ -7.36M€ -36.47M€ 12.61M€ 64.17M
EBITDA€ 45.48M€ 28.42M€ -22.15M€ 35.72M€ 83.35M
Net Income€ -21.31M€ -19.56M€ -51.44M€ 7.77M€ 47.26M
Balance Sheet
Cash & Short-Term Investments€ 74.53M€ 68.28M€ 95.71M€ 37.53M€ 136.30M
Total Assets€ 825.31M€ 756.58M€ 689.09M€ 575.78M€ 595.04M
Total Debt€ 130.46M€ 94.12M€ 113.66M€ 21.22M€ 18.00M
Net Debt€ 55.93M€ 25.84M€ 17.96M€ -16.31M€ -118.30M
Total Liabilities€ 484.98M€ 399.33M€ 307.86M€ 154.10M€ 173.87M
Stockholders' Equity€ 340.33M€ 357.24M€ 381.23M€ 421.68M€ 421.17M
Cash Flow
Free Cash Flow€ -30.44M€ 2.43M€ -20.25M€ -69.64M€ -16.61M
Operating Cash Flow€ 78.02M€ 89.40M€ 36.48M€ 5.46M€ 57.35M
Investing Cash Flow€ -112.44M€ -91.02M€ -59.51M€ -78.44M€ -80.84M
Financing Cash Flow€ 34.01M€ -25.32M€ 84.55M€ -26.87M€ 130.93M

Currency in EUR

PolyPeptide Group AG Earnings and Revenue History

-250M0250M500M-20 %0 %20 %40 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

PolyPeptide Group AG Liabilities to Assets

0300M600M900M20 %40 %60 %80 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

PolyPeptide Group AG Cash Flow

-150M-100M-50M050M100M150M20182019202020212022202320242025OperatingInvestingFinancing

PolyPeptide Group AG Forecast EPS vs Actual EPS

-1.5-1-0.500.51Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss